EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Does Testicular Sperm Improve Intracytoplasmic Sperm Injection Outcomes for Nonazoospermic Infertile Men with Elevated Sperm DNA Fragmentation? A Systematic Review and Meta-analysis

Christopher C Khoo, Axel Alberto Cayetano-Alcaraz, Razi Rashid, Tharu Tharakan, Tet Yap, Nikolaos Sofikitis, Andrea Salonia, Giovanni Corona, Aleksander Giwercman, Channa N Jayasena, Suks Minhas

European Urology Focus · 2024

DOI: 10.1016/j.euf.2023.08.008 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Urology Focus, 2024. Verfasst von Christopher C Khoo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Imperial College Healthcare NHS Trust, London, UK. Electronic address: christopher.khoo@nhs.net. Hauptthemen laut MEDLINE: Sperm Injections, Intracytoplasmic, DNA Fragmentation, Infertility, Male, Spermatozoa. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: NIHR Imperial Biomedical Research Centre, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CONTEXT: For nonazoospermic infertile men with elevated sperm DNA fragmentation (SDF), it is unclear whether the use of testicular sperm for intracytoplasmic sperm injection (ICSI) may offer advantages over ejaculated sperm. OBJECTIVE: To determine whether ICSI outcomes (fertilisation rate, pregnancy rate, miscarriage rate, and live birth rate) are better with testicular sperm than with ejaculated sperm for men with elevated SDF. EVIDENCE ACQUISITION: We searched the Cochrane Central, EMBASE, MEDLINE, Web of Science, and Scopus databases (1946-2023) in February 2023 for relevant human comparative studies according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. EVIDENCE SYNTHESIS: Out of 2032 records, nine studies (more than 536 participants, mean age range 33-40.5 yr for males and 30.1-37.9 yr for females) were included in the systematic review and meta-analysis. Pooled estimates demonstrated that the pregnancy rate was significantly higher with testicular than with ejaculated sperm according to a sperm chromatin structure assay (SCSA)/sperm chromatin integrity test (SCIT) (odds ratio [OR] 2.51; p = 0.001) and terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) assays (OR 3.65; p = 0.005). The live birth rate was significantly higher according to SCSA/SCIT (OR 2.59; p = 0.005). There were no significant differences in the fertilisation rate or miscarriage rate. CONCLUSIONS: Although significant improvements in pregnancy and live birth rates were observed with testicular sperm, the strength of findings is limited by availability and quality of evidence, both of which undermine recommendations for clinical practice. Standardised randomised controlled trials are needed to definitively determine whether the use of testicular sperm improves ISCI outcomes for men with high SDF. Until such evidence exists, ICSI after testicular sperm extraction or aspiration should not be routinely performed. PATIENT SUMMARY: Our review showed that for infertile men with a high level of DNA damage in their sperm, use of sperm extracted from the testicles may give better results than ejaculated sperm for a particular IVF (in vitro fertilisation) technique. However, there is a lack of high-quality data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sperm Injections, IntracytoplasmicDNA FragmentationInfertility, MaleSpermatozoaTestisHumansMalePregnancySperm RetrievalTreatment OutcomeFemalePregnancy Rate

Stichwörter der Autor:innen

Assisted reproductive technologyInfertilityIntracytoplasmic sperm injectionSperm DNA fragmentation

Autor:innen und Institutionen

  • Department of Urology, Imperial College Healthcare NHS Trust, London, UK. Electronic address: christopher.khoo@nhs.net.
  • Department of Urology, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Urology, Guy's and St. Thomas' NHS Trust, London, UK.
  • Department of Urology, Ioannina University School of Medicine, Ioannina, Greece.
  • Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; University Vita-Salute San Raffaele, Milan, Italy.
  • Endocrinology Unit, Azienda USL de Bologna, Bologna, Italy.

Förderung

  • NIHR Imperial Biomedical Research Centre
  • National Institute for Health and Care Research

Zitieren

APA

Khoo, C. C., Cayetano-Alcaraz, A. A., Rashid, R., Tharakan, T., Yap, T., Sofikitis, N., Salonia, A., Corona, G., Giwercman, A., Jayasena, C. N., & Minhas, S. (2024). Does Testicular Sperm Improve Intracytoplasmic Sperm Injection Outcomes for Nonazoospermic Infertile Men with Elevated Sperm DNA Fragmentation? A Systematic Review and Meta-analysis. European Urology Focus. https://doi.org/10.1016/j.euf.2023.08.008

Vancouver

Khoo CC, Cayetano-Alcaraz AA, Rashid R, Tharakan T, Yap T, Sofikitis N, et al. Does Testicular Sperm Improve Intracytoplasmic Sperm Injection Outcomes for Nonazoospermic Infertile Men with Elevated Sperm DNA Fragmentation? A Systematic Review and Meta-analysis. European Urology Focus. 2024. doi:10.1016/j.euf.2023.08.008

BibTeX
@article{Khoo2024,
  author = {Khoo, Christopher C and Cayetano-Alcaraz, Axel Alberto and Rashid, Razi and Tharakan, Tharu and Yap, Tet and Sofikitis, Nikolaos and Salonia, Andrea and Corona, Giovanni and Giwercman, Aleksander and Jayasena, Channa N and Minhas, Suks},
  title = {Does Testicular Sperm Improve Intracytoplasmic Sperm Injection Outcomes for Nonazoospermic Infertile Men with Elevated Sperm DNA Fragmentation? A Systematic Review and Meta-analysis},
  journal = {European Urology Focus},
  year = {2024},
  doi = {10.1016/j.euf.2023.08.008}
}
Kostenlos starten →